Previous 10 | Next 10 |
2023-12-18 09:51:23 ET More on Apple and Masimo Apple: Potential Healthcare Giant In The Making Is Apple's Valuation Undermining Your Retirement? (Rating Downgrade) Apple's Growth Engine App Store On The Hook For Billions Of Dollars At Risk Apple reportedly f...
2023-12-17 18:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
In the Largest Study of ORi to Date, of 554 Patients, Researchers Conclude: “ORi Can Provide Useful Information on Arterial Oxygenation Even During One-Lung Ventilation” Masimo (NASDAQ: MASI) today announced the findings of a retrospective study published in the Jour...
2023-12-07 04:59:03 ET More on Apple Apple Stock: Overvalued And Not For A Value Investor Apple: Great Business, Great Potential, But Not A Great Price Apple: Why The 10-Year Treasury May Offer Alpha Apple said to get new iPads, MacBook Air ready for 'early n...
2023-12-02 09:31:42 ET Summary Masimo's 'diworsification' deal for Sound United raised concerns among investors about the company moving away from its core expertise. The acquisition of Sound United led to a significant decrease in the value of Masimo, significantly exceeding the ...
Masimo (NASDAQ: MASI) today announced that its management will participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023 at 9:30 am ET. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the web...
2023-11-27 03:14:01 ET Summary Fundsmith's 13F portfolio value decreased by 8% to $22 billion in Q3 2023. The top three holdings in the portfolio are Microsoft, Stryker Corp, and Meta Platforms. New stakes were established in McDonald's and Oddity Tech, while stake disposals w...
2023-11-17 18:10:52 ET More on Masimo Masimo Corporation (MASI) Q3 2023 Earnings Call Transcript Masimo Corporation 2023 Q3 - Results - Earnings Call Presentation Masimo: Lots Of Questions Eminence Capital scoops up new stakes in Masimo, SentinelOne, exits Ne...
Masimo (NASDAQ: MASI) today announced that the Masimo W1™ medical watch has received FDA 510(k) clearance for over-the-counter (OTC) and prescription use (Rx). Masimo W1 is the first FDA-cleared watch to provide continuous real-time oxygen saturation (SpO 2 ) and pulse rate (PR) ...
2023-11-15 10:41:34 ET More on JFrog, Louisiana-Pacific, etc. Spectrum Brands Holdings: A Messy But Appealing Prospect Heading Into Q4 Earnings JFrog: A High-Quality Company With Little Margin of Safety Raymond James cuts Masimo to market perform, cites lack of visib...
News, Short Squeeze, Breakout and More Instantly...
Politan Will Take All Necessary Action to Ensure That the Annual Meeting Is Not Delayed Any Further Beyond September 19 and Hopefully Is Held Sooner Politan Capital Management (together with its affiliates, “Politan”), an 8.9% shareholder of Masimo Corporation (“Mas...
Masimo Corporation (“Masimo” or the “Company”) (Nasdaq: MASI), a global leader in noninvasive monitoring technologies and audio products, today announced that it has commenced litigation against Politan Capital Management LP (“Politan”) in federal court i...
To ensure that Politan lies repeated over and over are not taken as fact, Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI) sets forth below facts in response to what we believe are some of Politan’s and Quentin Koffey’s most egregious and con...